Uromedica, which develops urinary incontinence treatments, will find out in as soon as a few weeks if its medical device for men is ready for U.S. Food and Drug Administration approval application. The Minnesota medical device company submitted fresh data to the FDA that, if accepted, would be the basis for a premarket approval (PMA) application, CEO Tim Cook said. Uromedica sent the data, which included a … Comments RSS Post a comment. No comments yet.
Read the original:
Potential of male urinary incontinence treatment in U.S. could be …
Tags: application, approval, ceo, drug, fda, food, medical, minnesota, qd syringe systems